Pakistan’s pharmaceutical poised for U.S. market gains
Tariffs on India, deregulation boost industry; Citi Pharma eyes American expansion Pakistan’s pharmaceutical exports surged 34% to an all-time high of $457 million in fiscal year 2025, and analysts say U.S. tariffs on Indian competitors could open the door for even stronger growth ahead. The milestone, up from $341 million in FY24 and $328 million…